Androgenic Alopecia. Androgenic alopecia, unspecified
Conditions
Interventions
Intervention 1: Intervention group: on oral minoxidil tablet initial starting dose of 2.5 mg per day then gradually increasing the dose to maximum 5 mg per day for 6 months. Intervention 2: Control gr
Sponsors
Combined Military Hospital Quetta
Eligibility
Sex/Gender
Male
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Clinical diagnosis of AGA score 2-5 on Norwood-Hamilton classification. Age between 18-55 years. Patients who haven't received topical or systemic treatment for AGA within 3 months prior to the study.
Exclusion criteria
Exclusion criteria: Those with other causes of hair loss Such as inflammatory or scarring alopecia.any other types of alopecia History of severe systemic diseases ( renal, cardiovascular and hepatic) History of some hormonal disorders. History of hypertension,hypotension or on any antihypertensive therapy Hypersensitivity to minoxidil.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total hair density,hair thickness and total number of vellus and terminal hairs. Timepoint: Before start of study and after 1,2,3,6 Months after start of study. Method of measurement: Photographic pictures.;Patient's satisfaction score. Timepoint: Before study and after 6 months. Method of measurement: Interviewing with the patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Any side effects after taking minoxidil orally or topically. Timepoint: 3 monthly. Method of measurement: Interviewing with the patients and clinical examination. | — |
Countries
Pakistan
Contacts
Public ContactMoniba Saeed Sheikh
Combined Military Hospital
Outcome results
None listed